A recent study by the University of Bonn and University Hospital Bonn and the University of Freiburg shows that the mitochondria appear to be able to influence the number of lipid droplets in the cell ...

Cells rely on biomolecular condensates to coordinate essential biological processes without surrounding membranes. These droplet-like dynamic assemblies control the way in which DNA is turned into ...

Biomolecular condensates were long believed to be simple liquid blobs inside cells. Researchers have now uncovered that some are actually supported by fine protein filaments forming an internal ...

Tau proteins play an important role in our normal brain function, mainly by helping to stabilize neurons in the brain. But in Alzheimer’s disease, tau proteins can misfold and tangle inside neurons.

Researchers found that nonsense-mediated mRNA decay, via the UPF2 protein, is crucial for neuronal migration and cortical ...

A single genetic “switch” may be the secret to how the body’s cleanup crew grows up and keeps our organs running smoothly.

Researchers at the University of Liège have identified a key genetic regulator that enables macrophages to reach full maturity and preserve the health of our organs. The MafB factor, a veritable ...

A fleeting DNA fold called i‑DNA can switch cancer‑related genes on and off, revealing a hidden structural weak point that ...

Tau proteins play an important role in Alzheimer's disease. Tau helps to stabilize neurons in the brain, but in Alzheimer's disease, tau proteins can misfold and tangle inside neurons. These tangles ...

Researchers have discovered that modern vertebrate eyes evolved from an ancient one-eyed ancestor, linking the pineal gland ...

Germany is exploring controversial defence research creating bioelectronic insects for surveillance. A startup, SWARM Biotactics, is developing prototypes combining living insects with electronic ...

Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 study. | Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 ...